WSI Co Ltd
KOSDAQ:299170
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its 3-Year Average (6.8), the stock would be worth ₩527.39 (84% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 41.6 | ₩3 210 |
0%
|
| 3-Year Average | 6.8 | ₩527.39 |
-84%
|
| 5-Year Average | 6.4 | ₩496.09 |
-85%
|
| Industry Average | 22.5 | ₩1 736.76 |
-46%
|
| Country Average | 15.1 | ₩1 161.38 |
-64%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| KR |
W
|
WSI Co Ltd
KOSDAQ:299170
|
120.6B KRW | 41.6 | 602.3 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
101.2B USD | 12.5 | 23 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
60.7B USD | 20.2 | 37.4 | |
| US |
|
Cencora Inc
NYSE:COR
|
60.6B USD | 19.8 | 36.7 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
47.9B USD | 6.6 | 26.8 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
32B AUD | 40.5 | 35.2 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
62.8B CNY | 21.4 | 11 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
58.8B CNY | 136.9 | 20.7 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.5B USD | 9 | 21.6 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | -236.8 | 89.6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
58.6B HKD | -35.7 | 7.2 |
Market Distribution
| Min | 0.2 |
| 30th Percentile | 8.1 |
| Median | 15.1 |
| 70th Percentile | 28.4 |
| Max | 21 200 |
Other Multiples
WSI Co Ltd
Glance View
WSI Co., Ltd. manufactures medical devices and pharmaceutical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2018-09-21. The firm mainly distributes the topical hemostatic agent Flosils. In addition, the Company supplies endoscopes related to spinal surgery, anti-adhesion agents, and bone hemostatic agents.
